Analyst Price Targets — ARTV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 13, 2024 7:39 am | David Nierengarten | Wedbush | $18.00 | $11.22 | TheFly | Wedbush bullish on Artiva Biotherapeutics, initiates with an Outperform |
| August 13, 2024 6:51 am | Gil Blum | Needham | $23.00 | $11.22 | TheFly | Artiva Biotherapeutics initiated with a Buy at Needham |
Latest News for ARTV
SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced that Artiva management will participate in a panel as well as a fireside chat at the 25th Annual Needham Virtual Healthcare Conference…
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV - Get Free Report) saw a large decrease in short interest in the month of February. As of February 27th, there was short interest totaling 148,835 shares, a decrease of 21.3% from the February 12th total of 189,121 shares. Based on an average daily volume of 129,793 shares, the days-to-cover ratio
Initial clinical response data for AlloNK® in refractory rheumatoid arthritis (RA) expected in first half of 2026
SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced that Artiva management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on Wednesday, March 4,…
SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced the appointment of Thad Huston as Chief Financial Officer. Mr. Huston brings proven expertise in capital allocation, operational…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ARTV.
U.S. House Trading
No House trades found for ARTV.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.